Connect with us

Featured

Amid Growing Competition, Beyond Meat (BYND) Stock Price Struggles To Sustain At higher Levels

A. Lawrence

Published

on

beyond meat stock price

The market’s freshest technology stocks stumbled on Monday, performing worse than the major indexes and trailing the broader tech sector including Beyond Meat (BYND-Stock Info).

BYND stock faced a deep low after the announcement of news that its counterpart The Meatless Farm has managed to freeze a deal to sell its burgers at Whole Foods in the U.S. With the encroachment of the British rival, the shares of the company fell as much as 10%.

Beyond Meat Shares Slipped With The Arrival Of The Meatless Farm

With a startup in 2009, Beyond Meat which is a Los Angeles-based producer of plant-based meat substitutes has been one among the top performing IPO. However, the arrival of its rival has made the shares of the company go down. There has also been news that Meatless Farm would soon establish an office for operations in the New York City, as the company plans to expand its reach to the U.S. customers.

Read More | Can Marijuana Stocks Benefit From The Growth Of Beyond Meat?

“The market is really hitting up and it is a game changer to be working with Whole Foods Market. The US meat alternative market is currently the largest in the world and is strategically very important for the category.”

According to Rob Woodall, CEO of The Meatless Farm

The US is the fourth market outside of the UK for The Meatless Farm, which was founded in Leeds in 2017. The company also sells its meatless products in Canada, Sweden, and the UAE.

With the intentions of Meatless Farm loud and clear, it is a state of alarm for Beyond Meat. Beyond has so far sustained as the best-performing US IPO. It has also been accredited as the best performer of the year spiking as much as 700% from its offer price. But, with the news of immense competition, the shares of the company dwindled.

Competition Is Growing

While the arched rival Impossible Foods has been successful in working with Burger King, other major companies to enter the race of plant-based meat products are Tyson Foods (TYS-Stock Info) and Nestle (NSRGF-Stock Info). Keeping in mind the sensitivity of the stocks of Beyond Meat after the spilling of the news from Meatless Farm, the growing competition may pose a threat to the shares of Beyond Meat.

[Report] Two Massive Growth Industries, One Choice for Investors

Defending itself from its various competitors, the shares of Beyond Meat saw an upswing with the announcement of new ground beef product. Further, the broadcast of the availability of Beyond breakfast sandwiches at Tim Hortons across Canada helped the company sustain.

In the current scenario, it is difficult to anticipate if Beyond Meat will live up to the hype that’s sent its stock soaring.

Continue Reading
Click to comment

Featured

What Does The Disney (DIS) Plus, Amazon Deal Mean For Investors?

Jon Phillip

Published

on

DIS stocks to buy Disney +

There is no doubt that 2019 and the years beyond are going to be definite by the ‘streaming wars’ between some of the biggest companies in the world. The imminent entry of a behemoth like Disney (DIS) has raised the stakes even higher and on Thursday the entertainment company made another significant announcement.

During the company’s conference call for the fourth-quarter earnings, the Chief Executive Officer of Disney Bob Iger stated that the streaming serving Disney+ is going to be available on Amazon Fire TV.

[MARKET PREVIEW] The $40 Billion Dollar Content Gold Rush

Major Development For Content Providers

This is a major development, considering the fact that Disney had earlier said that the service might not be available on products owned by Amazon due to advertising disagreements.

However, that is not all. Iger went on to state that the service will also be made available on Smart TV manufactures by LG and Samsung. During the conference call, the Disney CEO said, “We’re pleased to announce partnerships with Amazon Fire [TV], LG, and Samsung devices.”

It is a major development for a streaming service that is trying to capture market share quickly from Netflix. Availability on Amazon Fire makes it accessible to a far bigger pool of potential customers. That is why this particular announcement is so important.

[MARKET PREVIEW] The $40 Billion Dollar Content Gold Rush

Where Does This Leave Netflix?

There are certain added benefits of the availability of Amazon Fire TV. The Disney+ app has the ability to sync with the built-in search engine on Amazon. Therefore, users will be able to request particular content by stating it to the personal assistant Alexa.

It goes without saying that the development has come as a big boost for Disney+. It’s ahead of the much-anticipated launch on November 12. The price of the service sits cheaper than Netflix’s cheapest package. It’s also going to be a highly cut-throat battle between the two companies. That said, other services are also coming soo. The ‘streaming wars’ are going to be the theme of 2020.

[MARKET PREVIEW] The $40 Billion Dollar Content Gold Rush

Continue Reading

Biotechnology

Biotech Stocks To Watch This Week

A. Lawrence

Published

on

make money with penny stocks biotech

With Biotech Continuing Higher, Are These Buys Or Sells This Week?

Biotech penny stocks have proven to be one of the best sectors for investments. That’s as far as the stock market is concerned. If experts are to be believed then it may continue to be among the best options in the years to come. That being said, it does not mean that investing in biotech stocks is an easy ride.

An investor needs to conduct a lot of research and also watch the market closely. Similar to other high-risk industries, volatility is a big factor. At any given point in time, a bad report could send stocks plummeting. Similarly, one good DA report can trigger a monster move. Here is a quick look at a few biotech penny stocks which made moves recently. Will they be better stocks to buy or avoid this month?

GT Biopharma Inc. (GTBP)

This company’s stock made new 3 month highs on October 22. GT Biopharma (GTBP) announced that its solid tumor targeting TriKE killed a non-small cell lung cancer tumor cell. This is a major development news for the company’s TriKE platform because the market potential for non-small lung cancer is big.

biotech stock to watch 2019

Non-small lung cancer accounts for 84% of all lung cancer diagnoses. Shareholders clearly felt this way, which may have been why GT Biopharma’s stock shot up by more than 25%.

There could be another potential reason why stockholders are reacting this way to the recent news. Earlier in October, the company announced that the design of HIV-TriKE was able to successfully target the HIV-Env protein.

This would allow the company’s TriKE technology to eliminate replicating HIV infected cells. Because of the success of TriKE with lung cancer cells, investors might feel that the company will be able to successfully destroy HIV cells. For more on GT Biopharma’s novel treatment pipeline and progress, click here.

WHAT CURING CANCER & HIV COULD MEAN FOR THIS COMPANY, ITS INVESTORS & THE WORLD!

Pieris Pharmaceuticals (PIRS)

The first stock to consider in the biotech sector with regards to the latest movements is that of Pieris Pharmaceuticals Inc (NASDAQ:PIRS). Back on November 5, the company announced that dose escalation monotherapy data with regards to one of its products is going to be presented at the Immunotherapy of Cancer (SITC) Annual Meeting that is going to be held at National Harbor, Maryland.

stock_price_mental

The medicine in question is PRS-343, which is meant for treating HER2-positive solid tumors. It goes without saying that it is a positive development and the Pieris stock has reacted positively to the news as well. Since the news broke, the stock has gained as much as 10%.

WHAT CURING CANCER & HIV COULD MEAN FOR THIS COMPANY, ITS INVESTORS & THE WORLD!

Foamix Pharmaceuticals (FOMX)

The other biotech stock that has been on a tear for much of the week is the Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) stock. Back on October 18, the company announced that one of its products known as AMZEEQ has been approved by the United States Food and Drug Administration. The medicine in question is a topical foam and is meant for treating inflammatory lesions in both adults as well as pediatric patients, who are older than 9. That was the initial trigger for the rise in the stock price.

Last week, the company also published a peer review of the long term open-label safety of AMZEEQ and that proved to be the trigger for the rally. During the course of the week so far, the Foamix stock has soared by as much as 60%. This is a stock that should definitely be tracked by investors.

WHAT CURING CANCER & HIV COULD MEAN FOR THIS COMPANY, ITS INVESTORS & THE WORLD!

biotechnology stocks to buy

Pursuant to an agreement between Midam Ventures LLC and GT Biopharma (GTBP), Midam has been paid $100,000 for a period from October 1, 2019 to November 15, 2019. We may buy or sell additional shares of GT Biopharma (GTBP) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about GT Biopharma (GTBP). Click Here For Full Disclaimer.

Continue Reading

Featured

Stock Price Newsletter – November 11, 2019

Joe Samuel

Published

on

biotech stocks to watch

Streaming Stocks Take Aim At Winning The Content War

Over the past half a decade or so, the world of entertainment changed dramatically with the emergence of video streaming service Netflix Inc (NASDAQ: NFLX). As cord-cutting grew, Netflix’s continued to corner more and more of the streaming market. Here is a look at a few tech stocks to watch that could be set to prove themselves on this new battlefield.

Click Here To Read More


3 Defense Stocks to Watch in November

Over the years it has become abundantly clear that defense spending is going to rise every year and hence, defense stocks have naturally emerged as some of the safest investments in the market. However, the current unstable geopolitical situation in different corners of the world could lead to even more defense spending, if a Bank of America analyst is to be believed.

See For Yourself


3 Popular Biotech Stocks To Watch in November

Over the years, the biotech sector has been a bit of a gold mine when it comes to stocks and thousands of investors have been able to make significant profits by backing the right companies. The innovative solutions and technical advancements that have been brought into the sector by different companies is another factor behind the continued growth.

Read More

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com